| Scott Andrew Muffly, MD | |
|
2331 Franklin Rd Sw, Roanoke, VA 24014-1111 | |
| (540) 510-6200 | |
| (540) 857-5306 |
| Full Name | Scott Andrew Muffly |
|---|---|
| Gender | Male |
| Speciality | Orthopaedic Surgery |
| Location | 2331 Franklin Rd Sw, Roanoke, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023515467 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | R-11148 (Iowa) | Secondary |
| 207X00000X | Orthopaedic Surgery | 0101279034 (Virginia) | Primary |
| Entity Name | Carilion Healthcare Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447206370 PECOS PAC ID: 5890607253 Enrollment ID: O20031106000273 |
News Archive
Scientists at VIB and KU Leuven have discovered that the protein APP plays a significant role in the development of fragile X syndrome (FXS) at young stages. They identified an unexpected biological pathway as a promising target to ameliorate deficits associated with FXS and autism. The results have recently been published in Neuron, one of the most influential journals in the field of neuroscience.
Medicago USA Inc., a wholly owned subsidiary of Medicago Inc., a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced it has received the fourth milestone payment of US$3.56 million from the Defense Advanced Research Projects Agency.
Dr Karin Heurlier and colleagues at the Universities of Nottingham and Birmingham in conjunction with Biolog Inc of California USA, used powerful high throughput analytical tools (phenotype microarrays) that enabled them to compare about 2000 growth characteristics of several pathogenic (disease-causing) E. coli with a non-pathogenic laboratory E. coli strain.
A team of researchers has discovered a genetic variation that doubles the risk for rheumatoid arthritis (RA).
› Verified 6 days ago
| Entity Name | Carilion Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730123472 PECOS PAC ID: 9830096585 Enrollment ID: O20040107000472 |
News Archive
Scientists at VIB and KU Leuven have discovered that the protein APP plays a significant role in the development of fragile X syndrome (FXS) at young stages. They identified an unexpected biological pathway as a promising target to ameliorate deficits associated with FXS and autism. The results have recently been published in Neuron, one of the most influential journals in the field of neuroscience.
Medicago USA Inc., a wholly owned subsidiary of Medicago Inc., a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced it has received the fourth milestone payment of US$3.56 million from the Defense Advanced Research Projects Agency.
Dr Karin Heurlier and colleagues at the Universities of Nottingham and Birmingham in conjunction with Biolog Inc of California USA, used powerful high throughput analytical tools (phenotype microarrays) that enabled them to compare about 2000 growth characteristics of several pathogenic (disease-causing) E. coli with a non-pathogenic laboratory E. coli strain.
A team of researchers has discovered a genetic variation that doubles the risk for rheumatoid arthritis (RA).
› Verified 6 days ago
| Entity Name | Carilion Rockbridge Community Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174636021 PECOS PAC ID: 4789658261 Enrollment ID: O20040820000838 |
News Archive
Scientists at VIB and KU Leuven have discovered that the protein APP plays a significant role in the development of fragile X syndrome (FXS) at young stages. They identified an unexpected biological pathway as a promising target to ameliorate deficits associated with FXS and autism. The results have recently been published in Neuron, one of the most influential journals in the field of neuroscience.
Medicago USA Inc., a wholly owned subsidiary of Medicago Inc., a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced it has received the fourth milestone payment of US$3.56 million from the Defense Advanced Research Projects Agency.
Dr Karin Heurlier and colleagues at the Universities of Nottingham and Birmingham in conjunction with Biolog Inc of California USA, used powerful high throughput analytical tools (phenotype microarrays) that enabled them to compare about 2000 growth characteristics of several pathogenic (disease-causing) E. coli with a non-pathogenic laboratory E. coli strain.
A team of researchers has discovered a genetic variation that doubles the risk for rheumatoid arthritis (RA).
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Scott Andrew Muffly, MD 213 S Jefferson St Ste 1006, Roanoke, VA 24011-1713 Ph: (540) 224-5352 | Scott Andrew Muffly, MD 2331 Franklin Rd Sw, Roanoke, VA 24014-1111 Ph: (540) 510-6200 |
News Archive
Scientists at VIB and KU Leuven have discovered that the protein APP plays a significant role in the development of fragile X syndrome (FXS) at young stages. They identified an unexpected biological pathway as a promising target to ameliorate deficits associated with FXS and autism. The results have recently been published in Neuron, one of the most influential journals in the field of neuroscience.
Medicago USA Inc., a wholly owned subsidiary of Medicago Inc., a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced it has received the fourth milestone payment of US$3.56 million from the Defense Advanced Research Projects Agency.
Dr Karin Heurlier and colleagues at the Universities of Nottingham and Birmingham in conjunction with Biolog Inc of California USA, used powerful high throughput analytical tools (phenotype microarrays) that enabled them to compare about 2000 growth characteristics of several pathogenic (disease-causing) E. coli with a non-pathogenic laboratory E. coli strain.
A team of researchers has discovered a genetic variation that doubles the risk for rheumatoid arthritis (RA).
› Verified 6 days ago
Dr. Peter James Apel, M.D., PH.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2331 Franklin Rd Sw, Roanoke, VA 24014 Phone: 540-510-6200 Fax: 540-857-5306 | |
James Mastin Farmer, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4633 Brambleton Ave Ste 200, Roanoke, VA 24018 Phone: 540-404-1111 Fax: 540-617-0110 | |
Lincoln Pratson, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 2331 Franklin Rd Sw, Roanoke, VA 24014 Phone: 540-510-6200 Fax: 540-857-5306 | |
Dr. Ryan Michael Putnam, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3 Riverside Cir, Roanoke, VA 24016 Phone: 540-510-6200 Fax: 540-857-5306 | |
Alden Hemenway Newcomb, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 2331 Franklin Rd Sw, Roanoke, VA 24014 Phone: 540-510-6200 Fax: 540-857-5306 | |
Murillo Adrados, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2331 Franklin Rd Sw, Roanoke, VA 24014 Phone: 540-510-6200 Fax: 540-857-5306 |